Itacitinib for the Prevention of Graft Versus Host Disease

NCT04859946 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Hematologic and Lymphocytic Disorder

Interventions

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Busulfan
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Itacitinib
DRUG: Tacrolimus
DRUG: Thiotepa

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]